Bristol-Myers Squibb (BMY) Tops Q1 EPS by 1c, Maintains EPS Guidance
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $56.63 -1.72%
EPS Growth %: +10.3%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: +10.3%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.10, $0.01 better than the analyst estimate of $1.09. Revenue for the quarter came in at $5.92 billion versus the consensus estimate of $5.76 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2019 EPS of $4.10-$4.20, versus the consensus of $4.19.
- Worldwide revenues increasing in the mid-single digits.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- UBS Reiterates Buy Rating on Zebra Technologies (ZBRA)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
